Stanley Druckenmiller at CNBC's Delivering Alpha on Sept. 28, 2022.Scott Mlyn | CNBCA version of this article first appeared in CNBC's Inside Wealth newsletter...
The Food and Drug Administration approved a once-daily HIV pill from Gilead that could help simplify care for some patients, the company announced Thursday. The...